Physician profile
Lynette Galloway
NPI 1124049622
$1,191.81
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $100 · 2023: $342 · 2024: $428 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $227.71 | 2021-2025 | |
| Angiodynamics, INC. | $129.17 | 2023 | Auryon Laser System 100-120 Vac |
| Mylan Specialty L.P. | $124.99 | 2024 | Yupelri |
| Mayne Pharma Commercial LLC | $124.74 | 2023 | |
| Exact Sciences Corporation | $105.29 | 2024 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $100.25 | 2022 | |
| Corcept Therapeutics | $100.00 | 2024 | Korlym |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $97.48 | 2024 | |
| Abiomed | $94.06 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynette Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.